Creative Medical Technology Holdings vs Alaunos Therapeutics
Creative Medical Technology Holdings is the larger business, with $6,000 of revenue in fiscal 2025 against $5,000 for Alaunos Therapeutics (1.2 times as much). Creative Medical Technology Holdings grew faster (-45.5% against -50.0%). Alaunos Therapeutics kept more of each dollar of sales as profit: a net margin of -83520.0% against -99916.8%. Creative Medical Technology Holdings carries less debt relative to equity (0.0% against 0.0%).
| Latest fiscal year | Creative Medical Technology HoldingsCELZ, 2025 | Alaunos TherapeuticsTCRT, 2025 |
|---|---|---|
| Revenue | $6,000 | $5,000 |
| Revenue growth | -45.5% | -50.0% |
| Net income | −$6.0m | −$4.2m |
| Operating margin | -102380.2% | -84500.0% |
| Net margin | -99916.8% | -83520.0% |
| Return on equity | -86.5% | -198.1% |
| Free cash flow | — | −$3.0m |
| Cash | $7.2m | $1.4m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $10,000 | — |
| Employees | — | — |
| Market value | $4.3m | $4.3m |
| Price vs our value range | — | — |
| Moat score | 35 (Weak) | 8 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |